Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients | European Respiratory Society - risk factors for Pseudomonas aeruginosa
Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins | Scientific Reports - Pseudomonas aeruginosa
Microorganisms | Free Full-Text | Relative Abundance and Detection of Pseudomonas aeruginosa from Chronic Wound Infections Globally - Pseudomonas aeruginosa
A c chart of the monthly incidence rate of Pseudomonas aeruginosa... | Download Scientific Diagram - of Pseudomonas aeruginosa
Pseudomonas aeruginosa bloodstream infection at a tertiary referral hospital for children | BMC Infectious Diseases | Full Text - Pseudomonas aeruginosa bloodstream
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients | European Respiratory Society - risk factors for Pseudomonas aeruginosa
For HCPs | Fight Pseudomonas - For HCPs | Fight Pseudomonas
Relationship between incidence density of Pseudomonas aeruginosa... | Download Scientific Diagram - Pseudomonas aeruginosa
Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014 - Yi Dou, Jingning Huan, Feng Guo, Zengding Zhou, Yan Shi, 2017 - Pseudomonas aeruginosa prevalence
Prevalence of a) Pseudomonas aeruginosa-community-acquired pneumonia... | Download Scientific Diagram - Prevalence of a) Pseudomonas aeruginosa
Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis - ScienceDirect - Prevalence of Pseudomonas aeruginosa
Antibiotics | Free Full-Text | Evaluation of Multidrug-Resistant P. aeruginosa in Healthcare Facility Water Systems - Multidrug-Resistant P. aeruginosa
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study - The Lancet Microbe - Global epidemiology and clinical
TropicalMed | Free Full-Text | Five-Year Antimicrobial Susceptibility of Pseudomonas aeruginosa from a Local Tertiary Hospital in Bacolod City, Philippines - Pseudomonas aeruginosa
A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections | Antimicrobial Resistance & Infection Control | Full Text - Antimicrobial Resistance & Infection
Prevalence of Pseudomonas aeruginosa in different hospital wards. | Download Scientific Diagram - Prevalence of Pseudomonas aeruginosa in
-
Phenotypic and genotypic within-host diversity of Pseudomonas aeruginosa urinary isolates | Scientific Reports - Pseudomonas aeruginosa urinary isolates
Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2015 - Pseudomonas aeruginosa Infections
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update | Drugs - Pseudomonas aeruginosa Infections
Antibiotics | Free Full-Text | Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa - Drug Resistant Pseudomonas aeruginosa
A citywide, clonal outbreak of Pseudomonas aeruginosa - International Journal of Infectious Diseases - Pseudomonas aeruginosa
Prevalence of β-lactamase and antibiotic-resistant Pseudomonas aeruginosa in the Arab region - ScienceDirect - Prevalence of β-lactamase and
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis - The Lancet Regional Health – Europe - Pseudomonas aeruginosa antibiotic
Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection | Future Microbiology - cystic fibrosis lung infection
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging - Global Pseudomonas Aeruginosa Infection
Pseudomonas aeruginosa - Information and Epidemiology Services - Pseudomonas aeruginosa - Information
TropicalMed | Free Full-Text | Epidemiological, Microbiological, and Clinical Characteristics of Multi-Resistant Pseudomonas aeruginosa Isolates in King Fahad Medical City, Riyadh, Saudi Arabia - Saudi Arabia
A Pseudomonas aeruginosa small RNA regulates chronic and acute infection | Nature - A Pseudomonas aeruginosa small RNA
Incidence of resistant Pseudomonas aeruginosa at University Hospital... | Download Scientific Diagram - resistant Pseudomonas aeruginosa
-
Epidemiology and Resistance of P. aeruginosa and A. baumanni | IDR - P. aeruginosa and A. baumanni
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine - Pseudomonas aeruginosa
Pseudomonas Aeruginosa Infection Treatment Market Size & Share Analysis - Industry Research Report - Growth Trends - Pseudomonas Aeruginosa Infection
Bacterial infections linked to one in eight global deaths, according to GRAM study — GRAM Project - Bacterial infections linked to one in
JCM | Free Full-Text | Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes? - Risk Factors for Mortality among
Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa | European Respiratory Society - Pseudomonas aeruginosa
Analytical methods for the characterization and diagnosis of infection with Pseudomonas aeruginosa: A critical review - ScienceDirect - Pseudomonas aeruginosa
Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation | Bone Marrow Transplantation - Invasive Pseudomonas aeruginosa
New results evidence new biomarkers for early diagnosis of P. aeruginosa infections - Nanbiosis - P. aeruginosa infections
Relative survival rates of P. aeruginosa-infected Galleria mellonella... | Download Scientific Diagram - Relative survival rates of P
Polymyxin B resistance rates in carbapenem‑resistant Pseudomonas aeruginosa isolates and a comparison between Etest® and broth microdilution methods of antimicrobial susceptibility testing - Polymyxin B resistance rates in
Pseudomonas Aeruginosa Infection Treatment Market Size & Share Analysis - Industry Research Report - Growth Trends - Pseudomonas Aeruginosa Infection
-
Pseudomonas Aeruginosa Features, Infections & Treatments - Video & Lesson Transcript | Study.com - Pseudomonas Aeruginosa Features
Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa B | IDR - Pseudomonas aeruginosa
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics | Signal Transduction and Targeted Therapy - Pseudomonas aeruginosa: pathogenesis
Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa | European Respiratory Society - Pseudomonas aeruginosa
Seasonal humidity may influence Pseudomonas aeruginosa hospital-acquired infection rates - ScienceDirect - Seasonal humidity may influence
Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry - Journal of Cystic Fibrosis - respiratory bacteriology
Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus | SpringerLink - Staphylococcus aureus
30 day all-cause mortality following MRSA, MSSA and Gram-negative bacteraemia and C. difficile infections: 2022 to 2023 report - GOV.UK - C. difficile infections
Full article: The contribution of Pseudomonas aeruginosa infection to clinical outcomes in bronchiectasis: a prospective cohort study - Pseudomonas aeruginosa infection
Early Avycaz Therapy Increases Success Rates for MDR P. aeruginosa Pneumonia - MDR P. aeruginosa Pneumonia
Pseudomonas aeruginosa bloodstream infection at a tertiary referral hospital for children | BMC Infectious Diseases | Full Text - Pseudomonas aeruginosa bloodstream
